Clinical Trials Browser

Prostatic Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Hematologic Neoplasms

NCT05332054 2026-03-12

LTFS

Enrolling by invitation

150 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Hematologic Neoplasms

NCT05041309 2026-02-25

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

Enrolling by invitation

1,000 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT00001620 2026-02-17

Screening for Hematology Branch Protocols

Enrolling by invitation

10,000 enrolled

Classical hematologyOther hematologic neoplasm

Cytopenia, Anemia, Disease, Hematologic Diseases, Neutropenia, Thrombocytopenia, Hematologic Neoplasms

NCT02315599 2026-01-14

Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials

Enrolling by invitation

500 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT06967467 2025-12-18

RENEW-EVAL

Enrolling by invitation

80 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT02473757 2025-12-01

Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies

Enrolling by invitation

1,000 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Leukemia, B-Cell, Hematologic Neoplasms

NCT05600933 2025-09-15

Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment

Enrolling by invitation

1,200 enrolled

DermatologicGastrointestinalOther hematologic neoplasmThoracic

Gastrointestinal Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Pancreatic Neoplasms, Hematologic Neoplasms

NCT07172191 2025-09-15

HEMAT-FMT

Phase NA Enrolling by invitation

100 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT06208878 2025-08-14

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Enrolling by invitation

70 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT06925685 2025-04-13

Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product

Enrolling by invitation

50 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

Clinical Trials

PERSIST

LTFS

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

Screening for Hematology Branch Protocols

Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials

RENEW-EVAL

Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies

Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment

HEMAT-FMT

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product